PWMG
IMVT icon

Private Wealth Management Group’s Immunovant IMVT Stock Holding History

Private Wealth Management Group’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.93K Hold
128
– – ﹤0.01% 850
2026
Q1 		$3.18K Hold
128
– – ﹤0.01% 926
2025
Q4 		$3.25K Hold
128
– – ﹤0.01% 923
2025
Q3 		$2.06K Hold
128
– – ﹤0.01% 1106
2025
Q2 		$2.05K Buy
128
+22
+21% +$333 ﹤0.01% 1078
2025
Q1 		$1.81K Buy
+106
New +$2.22K ﹤0.01% 1088

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Private Wealth Management Group's IMVT Position: Q2 2026 in Review

Private Wealth Management Group held its Immunovant (IMVT) position steady in Q2 2026 at 128 shares worth $4.93K. The position accounts for ﹤0.01% of the portfolio, ranked #850.

Private Wealth Management Group first reported a position in IMVT in Q1 2025 and has held it in 6 quarters since. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Private Wealth Management Group held 128 shares of Immunovant worth $4.93K as of Q2 2026.
  • Private Wealth Management Group left its Immunovant share count unchanged in Q2 2026.
  • Immunovant made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #850 holding.
  • Private Wealth Management Group first reported a position in Immunovant in Q1 2025 and has held it in 6 quarters since.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.